Our findings propose that when the TME is enriched with both cytokines, as may often be the case in malignancy (20–26), TNFα + TGFβ1 would act not only on the tumor cells but also may induce the release of pro-inflammatory and tumor-promoting factors by MSCs. Here, TGFB1 is linked to neoplasm.